FRIDAY, Sept. 18, 2020 (Healthday News) — New details surfaced on Thursday on an unexplained neurological condition that struck a volunteer who was participating in AstraZeneca’s coronavirus vaccine trial. In an internal safety report obtained by CNN, company officials describe how a healthy 37-year-old woman “experienced confirmed transverse myelitis” afterContinue Reading

THURSDAY, Sept. 17, 2020 (HealthDay News) — There are “substantial” rates of coronavirus infection in dogs and cats whose owners have COVID-19, new research shows. The researchers also found that, in several cases, infected pets had COVID-like respiratory symptoms at the time their owners were infected. SARS-CoV-2 has been reportedContinue Reading

WEDNESDAY, Sept. 16, 2020 (Healthday News) — A single infusion of an experimental drug dramatically lowers levels of coronavirus in the bodies of newly infected patients and cuts their chances of hospitalization, the drug’s maker reported Wednesday. Eli Lilly’s announcement did not include detailed data and hasn’t been peer-reviewed orContinue Reading

WEDNESDAY, Sept. 9, 2020 (Healthday News) — Final testing of a leading coronavirus vaccine candidate was paused by drugmaker AstraZeneca on Tuesday after a trial volunteer experienced a serious adverse reaction. The company did not release specifics on the case, but whether the reaction was caused by the vaccine orContinue Reading